STOCK Mmp9tm1a(EUCOMM)Wtsi/IcsOrl

Status

Available to order

EMMA IDEM:09960
International strain nameSTOCK Mmp9tm1a(EUCOMM)Wtsi/IcsOrl
Alternative nameEPD0844_5_F12
Strain typeTargeted Mutant Strains
Allele/Transgene symbolMmp9tm1a(EUCOMM)Wtsi
Gene/Transgene symbolMmp9
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0844_5_F12. For further details on the construction of this clone see the page at the IKMC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6NTac

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
  • delayed bone ossification / MGI
  • osteopetrosis / MGI
  • abnormal trabecular bone morphology / MGI
  • abnormal long bone hypertrophic chondrocyte zone / MGI
  • increased monocyte cell number / MGI
  • abnormal megakaryocyte differentiation / MGI
  • abnormal angiogenesis / MGI
  • altered response to myocardial infarction / MGI
  • abnormal myelination / MGI
  • increased body weight / MGI
  • decreased metastatic potential / MGI
  • reduced long term potentiation / MGI
  • impaired myelopoiesis / MGI
  • impaired hematopoiesis / MGI
  • myocarditis / MGI
  • lung inflammation / MGI
  • decreased inflammatory response / MGI
  • reduced fertility / MGI
  • decreased litter size / MGI
  • decreased tumor incidence / MGI
  • abnormal dendritic cell physiology / MGI
  • decreased susceptibility to viral infection / MGI
  • decreased susceptibility to bacterial infection / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal neutrophil physiology / MGI
  • decreased IgE level / MGI
  • increased IgE level / MGI
  • short tibia / MGI
  • increased susceptibility to dystrophic cardiac calcinosis / MGI
  • delayed wound healing / MGI
  • joint inflammation / MGI
  • joint swelling / MGI
  • thick ventricular wall / MGI
  • abnormal cytokine secretion / MGI
  • decreased myocardial infarction size / MGI
  • hypoalgesia / MGI
  • abnormal long bone epiphyseal plate morphology / MGI
  • increased vascular permeability / MGI
  • abnormal metatarsal bone morphology / MGI
  • short femur / MGI
  • abnormal impulse conducting system conduction / MGI
  • cardiac fibrosis / MGI
  • decreased neuron apoptosis / MGI
  • increased width of hypertrophic chondrocyte zone / MGI
  • decreased susceptibility to induced arthritis / MGI
  • abnormal tumor morphology / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • abnormal physiological neovascularization / MGI
  • abnormal myocardial fiber physiology / MGI
  • decreased length of long bones / MGI
  • decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
  • abnormal hematopoietic stem cell morphology / MGI
  • abnormal vascular wound healing / MGI
  • increased eosinophil cell number / MGI
  • increased lymphocyte cell number / MGI
  • abnormal response to infection / MGI
  • decreased cardiac muscle contractility / MGI
  • decreased susceptibility to injury / MGI
  • abnormal blood-brain barrier function / MGI
  • increased T cell proliferation / MGI
  • abnormal Langerhans cell physiology / MGI
  • immune system phenotype / MGI
  • increased macrophage cell number / MGI
  • abnormal vascular smooth muscle physiology / MGI
  • increased ventricle muscle contractility / MGI
  • increased angiogenesis / MGI
  • increased susceptibility to type IV hypersensitivity reaction / MGI
  • decreased susceptibility to ischemic brain injury / MGI
  • abnormal retinal apoptosis / MGI
  • aortic aneurysm / MGI
  • increased T-helper 2 cell number / MGI
  • decreased dendritic cell number / MGI
  • abnormal leukocyte morphology / MGI
  • decreased susceptibility to induced colitis / MGI
  • increased interferon-gamma secretion / MGI
  • decreased interferon-gamma secretion / MGI
  • increased circulating interferon-beta level / MGI
  • increased circulating interferon-gamma level / MGI
  • decreased circulating interleukin-10 level / MGI
  • increased interleukin-13 secretion / MGI
  • increased interleukin-4 secretion / MGI
  • increased interleukin-5 secretion / MGI
  • abnormal chemokine level / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • abnormal bone marrow cell physiology / MGI
  • increased tibialis anterior weight / MGI
  • impaired contextual conditioning behavior / MGI
  • abnormal induced retinal neovascularization / MGI
  • increased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • decreased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • decreased susceptibility to viral infection induced morbidity/mortality / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI
  • decreased oligodendrocyte number / MGI
  • increased prostaglandin level / MGI
  • thick interventricular septum / MGI
  • decreased histamine level / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).